Analyst Price Targets — CVS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 19, 2026 12:45 pm | — | Argus Research | $114.00 | $95.58 | TheFly | CVS Health price target raised to $114 from $104 at Argus |
| August 6, 2026 1:20 pm | Michael Ha | Robert W. Baird | $107.00 | $96.96 | TheFly | CVS Health price target raised to $107 from $94 at Baird |
| August 6, 2026 10:17 am | Kevin Caliendo | UBS | $126.00 | $99.12 | StreetInsider | CVS Health (CVS) PT Raised to $126 at UBS |
| August 6, 2026 9:15 am | — | Barclays | $108.00 | $99.12 | TheFly | CVS Health price target raised to $108 from $106 at Barclays |
| July 24, 2026 12:32 pm | — | UBS | $122.00 | $107.85 | TheFly | CVS Health price target raised to $122 from $115 at UBS |
| July 14, 2026 11:49 am | David MacDonald | Truist Financial | $118.00 | $105.90 | TheFly | CVS Health price target raised to $118 from $108 at Truist |
| July 13, 2026 11:05 am | — | Wells Fargo | $123.00 | $104.15 | TheFly | CVS Health price target raised to $123 from $103 at Wells Fargo |
| July 9, 2026 12:12 pm | — | RBC Capital | $113.00 | $104.83 | TheFly | CVS Health price target raised to $113 from $107 at RBC Capital |
| July 7, 2026 11:23 am | — | Cantor Fitzgerald | $110.00 | $102.08 | StreetInsider | CVS Health (CVS) PT Raised to $110 at Cantor Fitzgerald Post ChecksMember Login |
| July 6, 2026 2:21 pm | — | HSBC | $103.00 | $102.28 | TheFly | CVS Health price target raised to $103 from $85 at HSBC |
Latest News for CVS
Here's How CVS' Improving Balance Sheet Supports Deleveraging
CVS Health's strong cash generation, higher operating cash flow outlook and disciplined capital deployment support continued deleveraging in 2026.
Why CVS Stock Rallied Tuesday Morning
CVS was called a "top pick" by one Wall Street analyst. The healthcare giant's recovery is gaining traction.
CVS vs. UNH: Which Health Insurance Stock Has More Upside Now?
UnitedHealth Group's stronger six-month return, improving UnitedHealthcare and Optum results and attractive valuation make it the better buy.
Wall Street Isn't Giving Up on CVS Health -- and Its Valuation Looks Stronger Than Investors Think
CVS reported triple-digit earnings growth in the second quarter. The company also upgraded its yearly guidance.
Why CVS Health (CVS) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.